Researchers highlight the need for multidisciplinary collaboration in medicine, especially in addressing transmissible illnesses, precision medicine, and data science, as learned from the COVID-19 pandemic.
Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers
Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a preclinical pipeline of
October 4, 2024